Showing results (121-130 of 151) with videos related to
Sort By:
Pageof 16
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 15, 2002
Mathematical modelling and quantitative methodsL Edler, K Poirier, M Dourson, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
(5S,6R)-5-Methyl-6-phenyl-4-propyl-1,3,4-oxadiazinane-2-thioneJoshua L Kocher, Kate L Edler, Barbara A Bohling, et al.Cancer Biology & Therapy|November 19, 2005
Corticosteroid-induced chemotherapy resistance in urological cancersC Zhang, J Mattern, A Haferkamp, et al.Methods of Information in Medicine|October 17, 2007
New bioinformatic strategies to rapidly characterize retroviral integration sites of gene therapy vectorsF A Giordano, A Hotz-Wagenblatt, D Lauterborn, et al.Onkologie|June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"U Räth, H Flechtner, J Selbach, et al.Journal of Molecular Medicine (Berlin, Germany)|April 12, 2000
Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trialsR Breitkreutz, N Pittack, C T Nebe, et al.Pharmacogenetics|December 12, 2001
Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomasA Risch, H Wikman, S Thiel, et al.Klinische Wochenschrift|February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvumD Fritze, B Massner, R Becher, et al.Onkologie|June 1, 1990
Phase II study of pirarubicin in metastatic breast cancerU R Kleeberg, L Reichel, H E Wander, et al.Archives of Toxicology|January 1, 1994
Porphyrin studies in TCDD-exposed workersD Jung, J Konietzko, G Reill-Konietzko, et al.Pageof 16